厄他培南是否影响假单胞菌对其他碳青霉烯类抗生素的敏感性？
Carbapenem stewardship:does ertapenem affect Pseudomonas susceptibility to other carbapenem?A review of the evidence
摘要
第2组碳青霉烯类抗生素(亚胺培南、美罗培南以及最近上市的多立培南)一直是铜绿假单胞菌、肠杆菌科细菌、其他难治性革兰阴性菌、以及需氧/厌氧菌混合感染导致的严重医院感染的支柱治疗药物。第1组碳青霉烯类抗生素厄他培南面市时,厄他培南的临床应用是否会选择出对亚胺培南和美罗培南耐药的假单胞菌这一问题随之而来。10项临床研究评估了应用厄他培南对假单胞菌属对第2组碳青霉烯类抗生素敏感性的影响,结果一致显示,应用厄他培南不会降低假单胞菌对第2组碳青霉烯类抗生素的敏感性。现对上述研究进行回顾分析,为厄他培南的临床应用提供参考。
出处
《中国感染与化疗杂志》
CAS
北大核心
2013年第3期235-240,共6页
Chinese Journal of Infection and Chemotherapy
参考文献19
-
1Weber D. Collateral damage and what the future might hold. The need tobalancc prudent antibiotic utilization and steward ship with effective patientmanagement[J]. Int J Infect Dis, 2005,10(Suppl 2):s17-s24.
-
2Vincent J, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care u nits[J]. JAMA,2009,302(21) :2323-2329.
-
3dos Santos RP, Jacoby T, Goldani LZ. Antimicrobial stew-ardship lessons: do Pseudomonas-sparing agents, such as ertapenem, effectively improve bacterial resistance? [J]. Anti microb Agents Chemother, 2010,54(7) :3076-3077.
-
4Paterson D. "Collateral damage" from cephalosporin or quinolone antibiotic therapy[J]. Clin Infect Dis, 2004,38 Suppl 4 : s341-s345.
-
5Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update[J]. Clin Microbiol Rev, 2005,18 (4) : 657-686.
-
6Goldstein EJ, Citron DM, Peraino V, et al. Introduction of ertapenem into a hospital formulary: effect on antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosa [J]. Antimicrob Agents Chemother, 2009, 53 (12) :5122-5126.
-
7Golf DA, Mangino JE. Ertapenem: no effect on aerobic gram-negative susceptibilities to imipenem[J]. J Infect, 2008,57(2): 123-127.
-
8Eagye KJ, Nicolau DP. Absence of association between use of ertapenem and change in antipseudomonal carbapenem susceptibility rates in 25 hospitals[J]. Infect Control Hosp Epidemiol, 2010, 31(5):485-490.
-
9Eagye K J, Nicolau DP. Change in antipseudomonal carbapen em susceptibility in 25 hospitals across 9 years is not assoeiat ed with the use of ertapenem[J]. J Antimicrob Chemother 2011,66(6) :1392-1395.
-
10Lima AL, Oliveira PR, Paula AP, et al. The impact of ertapenem use on the susceptibility of Pseudomonas aeruginosa to imipenem:a hospital case study[J]. Infect Control Hosp Epidemiol, 2009,30 ( 5 ) : 487-490.
-
1陆武,沈红芬,刘军.抗菌药物致肠道菌群失调的机制及防治[J].药学服务与研究,2009,9(3):222-224. 被引量：22
-
2王亚茹.抗2型糖尿病药物的合理应用新进展[J].黑龙江医药,2014,27(2):348-350. 被引量：1
-
3J.B.Maathuis,周丽瀛.口服避孕药——避孕的支柱[J].生殖医学杂志,1999,8(4):201-202.
-
4喹诺酮耐药性的生态学情况:传播与控制[J].国外医药（抗生素分册）,2001,22(6):284-284.
-
5肥胖与阴沟杆菌有直接关系[J].家庭医学（上半月）,2013(2):32-32.
-
6石宁江.抗幽门螺杆菌药物治疗中的生态学问题[J].医药导报,1998,17(6):357-358.
-
7欧军林.微笑的支柱——世界主要抗抑郁药物[J].中国处方药,2003(4):28-29.
-
8张杰,张亚芝.野生龙胆的生态学调查[J].长春中医药大学学报,2007,23(2):36-36. 被引量：12
-
9朱愿超,胡永芳,杨莉萍,胡欣.Impact of clinical pharmacist intervention on rational use of surgical antibiotic prophylaxis in thyroid surgery[J].Journal of Chinese Pharmaceutical Sciences,2015,24(9):617-624.
-
10季宪锋.低分子量肝素预防心房颤动患者血栓事件的临床研究[J].辽宁药物与临床,2004,7(1):20-22.
